Cut-out-Rescan Procedure Under Different Rubber-Dam Isolation
Launched by MARMARA UNIVERSITY · Mar 24, 2025
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
The CAD/CAM system has been in use in the industry for decades and has been popular in recent years with its use in many areas of dentistry. These systems' numerous advantages over conventional methods, coupled with the ongoing advancement of intraoral scanner technologies, have led to their frequent preference among clinicians. It is well known that the method of rescanning, which is frequently employed in clinical settings to acquire data from previous, can also affect the accuracy of the results. In addition, it has been observed that the efficacy of the rescanning method varies dependin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • l8-65 age range
- • Have sufficient cognitive ability to understand the consent procedure
- • To have clinically healthy gingiva and periodontium
- • Daily cigarette consumption of 10 cigarettes or less
- • No loss of attachment, bleeding or plaque accumulation on probing
- • Vital mandibular teeth without signs of irreversible pulpitis
- • Caries in the right or left lower 2nd premolar tooth suitable for direct composite restoration indication
- • The 1st molar, 2nd molar, 1st premolar and canine teeth in the relevant region are not missing and do not contain any fixed prosthesis
- Exclusion Criteria:
- • Any disability (mental health conditions, mental disabilities and physical disabilities)
- • Systemic diseases or medically serious risks (cardiovascular disorder, diabetes, hypertensive, epileptic)
- • Gingival hyperplasia or periodontal disease
- • Symptoms of periapical or pulpal pathology
- • Non-vital endodontically treated teeth
- • Teeth showing mobility
- • Congenital tooth deficiencies
- • Having a prominent crossbite, missing teeth, jaw anomaly or prosthetic restoration in the relevant region
About Marmara University
Marmara University is a distinguished academic institution located in Istanbul, Turkey, renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust infrastructure and a multidisciplinary approach, the university actively engages in the development and evaluation of new therapeutic interventions, fostering collaboration among researchers, clinicians, and industry partners. Marmara University’s focus on ethical standards and patient safety underscores its dedication to contributing valuable insights to the medical community and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Maltepe, Turkey
Patients applied
Trial Officials
Bora Korkut, Associate Professor
Principal Investigator
Marmara University
Ayşe Aslı Şenol, Asisstant Professor
Study Director
Marmara University
Cevdet Can Saygılı, Research assistant
Principal Investigator
Marmara University
Bengü Doğu Kaya, Asisstant Professor
Principal Investigator
Çanakkale Onsekiz Mart Univesity
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported